Bringing the fundamentals into focus…
Bringing the fundamentals into focus…
ENOV · against 419 other Healthcare companies of similar size
Ranked #172 of 420 · scores higher than 58% of peers
Bars: peers in each 10-point band of the growth score36 peers with a growth score of 50–59, including ENOV · Click a bar to see the companies
Its metrics sit close to the Healthcare norm.
| Metric | ENOV | Peer median | Better than | Position among peers | Weight |
|---|---|---|---|---|---|
| Revenue growthHigher is better · 426 reported | 6.7% | 5.2% | 54% | 33% | |
| Earnings per share growthHigher is better · 237 reported | Not reported | 7.6% | — | — | 33% |
| 3-year revenue growthHigher is better · 412 reported | 12.9% | 5.8% | 68% | 33% |
A metric that is not reported is left out of the score; the other weights are rescaled.
| Rank | Company | Market cap | Growth | Overall |
|---|---|---|---|---|
| 1 | 8.9B HKD (≈$1.1B) | 99 | 61 | |
| 1 | 1.4B USD | 99 | 73 | |
| 1 | 2.1B USD | 99 | 96 | |
| 1 | 885M USD | 99 | 33 | |
| 1 | 15.6B DKK (≈$2.3B) | 99 | 96 | |
| 170 | 2.2B USD | 60 | 36 | |
| 170 | 2.2B USD | 60 | 61 | |
| 172 | 5.1B CNY (≈$719M) | 59 | 74 | |
| 172 | 1.2B CHF (≈$1.4B) | 59 | 34 | |
| 172 | 1.2B USD | 59 | 46 | |
| 172 | 1.0B USD | 59 | 74 | |
| 172 | 1.6B USD | 59 | 30 | |
| 177 | 114.7B JPY (≈$780M) | 58 | 72 | |
| 178 | 11.3B CNY (≈$1.6B) | 57 | 76 |
Scores are sector-relative percentiles from the latest snapshot, always calculated against the whole sector: narrowing the comparison group changes who you compare with, not the scores. Missing metrics are left out and the remaining weights rescaled. How we score